Compare Revvity Inc (RVTY) vs NEOS S&P 500 High Income ETF (SPYI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs NEOS S&P 500 High Income ETF — how do they compare? Revvity Inc trades at $117.6 (market cap $12.91B), while NEOS S&P 500 High Income ETF trades at $54.2. The key difference: Revvity Inc pays a 0.24% dividend while NEOS S&P 500 High Income ETF pays none. Which is the better fit depends on your goals.
| RVTY | SPYI | |
|---|---|---|
Market Cap | $12.91B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $117.75 | $54.19 |
52-Week Low | $82.26 | $47.98 |
Enterprise Value | $15.23B | — |
Dividend Yield | 0.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
SPYI (NEOS S&P 500 High Income ETF) trades at $54.20, showing minimal daily movement with a 0.02% gain. The ETF employs an options overlay strategy on the S&P 500 to generate high monthly distributions, with recent dividends of $0.53-$0.54. Technical indicators show a bullish trend with strong moving average support, though RSI levels suggest potential overbought conditions. The fund's primary appeal is its ability to provide substantial income while maintaining S&P 500 exposure.
SPYI offers investors a unique income-generating approach through its options strategy, currently yielding approximately 12%. However, concerns exist about whether distributions represent true income versus return of capital. The fund's performance depends heavily on market volatility for option premium generation, creating both opportunity and risk. Investors should weigh the high yield against potential principal erosion in low-volatility environments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About NEOS S&P 500 High Income ETF
SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.
Read more on SPYI →
